The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how generic pharmaceuticals stocks fared in Q4, starting with ...
Feb 26 (Reuters) - Drugmaker Viatris (VTRS.O), opens new tab forecast annual profit below analysts' expectations on Thursday, after a fire at one of its major plants in India disrupted operations. A ...
Is On Investors’ Radar Viatris (VTRS) is drawing attention after a mixed stretch in its share performance, with a negative move over the past month but a positive total return over the past 3 months ...
Viatris Inc. (NASDAQ:VTRS) is included among the 14 Best Pharma Dividend Stocks to Buy in 2026. On December 9, Barclays analyst Glen Santangelo initiated coverage of Viatris Inc. (NASDAQ:VTRS) with an ...
Viatris (VTRS) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one of ...
PITTSBURGH, Feb. 3, 2026 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced it will report fourth quarter and full year 2025 financial results on Thursday, ...
Add Yahoo as a preferred source to see more of our stories on Google. Feb 26 (Reuters) - Drugmaker Viatris forecast annual profit below analysts' expectations on Thursday, after a fire at one of its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results